Skip to main content
SpringerLink
Log in

Apixaban/thalidomide

Rash and major bleeding : 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Storrar NPF, et al. Safety and efficacy of apixaban for routine thromboprophylaxis in myeloma patients treated with thalidomide- and lenalidomide-containing regimens. British Journal of Haematology 185: 142-144, No. 1, Apr 2019. Available from: URL: http://doi.org/10.1111/bjh.15392 - UnitedKingdom

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Apixaban/thalidomide. Reactions Weekly 1750, 49 (2019). https://doi.org/10.1007/s40278-019-60913-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-60913-x

Search

Navigation